1.Clinical, Biochemical and Genetic Analyses in Two Korean Patients with Medium-chain Acyl-CoA Dehydrogenase Deficiency.
Hye In WOO ; Hyung Doo PARK ; Yong Wha LEE ; Dong Hwan LEE ; Chang Seok KI ; Soo Youn LEE ; Jong Won KIM
The Korean Journal of Laboratory Medicine 2011;31(1):54-60
Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is an autosomal recessive hereditary metabolic disorder of mitochondrial fatty acid beta-oxidation. It is characterized by hypoketotic hypoglycemia, hyperammonemia, seizure, coma, and sudden infant death syndrome-like illness. The most frequently isolated mutation in the acyl-CoA dehydrogenase, medium-chain (ACADM) gene of Caucasian patients with MCADD is c.985A>G, but ethnic variations exist in the frequency of this mutation. Here, we describe 2 Korean pediatric cases of MCADD, which was detected during newborn screening by tandem mass spectrometry and confirmed by molecular analysis. The levels of medium-chain acylcarnitines, including octanoylcarnitine (C8), hexanoylcarnitine (C6), and decanoylcarnitine (C10), were typically elevated. Molecular studies revealed that Patient 1 was a compound heterozygote for c.449_452delCTGA (p.Thr150ArgfsX4) and c.461T>G (p.L154W) mutations, and Patient 2 was a compound heterozygote for c.449_452delCTGA (p.Thr150ArgfsX4) and c.1189T>A (p.Y397N) mutations. We detected asymptomatic patients with MCADD by using a newborn screening test and confirmed it by ACADM mutation analysis. This report presents evidence of the biochemical and molecular features of MCADD in Korean patients and, to the best of our knowledge, this is the first report of the c.461T>G mutation in the ACADM gene.
Acyl-CoA Dehydrogenase/chemistry/deficiency/genetics
;
Asian Continental Ancestry Group/*genetics
;
Base Sequence
;
Biological Markers/blood
;
Carnitine/analogs & derivatives/blood
;
DNA Mutational Analysis
;
Exons
;
Female
;
Gene Deletion
;
Heterozygote
;
Humans
;
Infant, Newborn
;
Lipid Metabolism, Inborn Errors/diagnosis/genetics
;
Male
;
Mutation
;
Neonatal Screening
;
Republic of Korea
;
Tandem Mass Spectrometry
2.Miller-Dieker Syndrome with der(17)t(12;17)(q24.33;p13.3)pat Presenting with a Potential Risk of Mis-identification as a de novo Submicroscopic Deletion of 17p13.3.
Young Jin KIM ; Shin Yun BYUN ; Seon A JO ; Yong Beom SHIN ; Eun Hae CHO ; Eun Yup LEE ; Sang Hyun HWANG
The Korean Journal of Laboratory Medicine 2011;31(1):49-53
Miller-Dieker syndrome involves a severe type of lissencephaly, which is caused by defects in the lissencephaly gene (LIS1). We report the case of a female infant with der(17)t(12;17)(q24.33;p13.3)pat caused by an unbalanced segregation of the parental balanced translocation of 17p with other chromosomes. The proband presented with facial dysmorphism, arthrogryposis, and intrauterine growth retardation. Most cases of Miller-Dieker syndrome have a de novo deletion involving 17p13.3. When Miller-Dieker syndrome is caused by an unbalanced translocation, mild-to-severe phenotypes occur according to the extension of the involved partner chromosome. However, a pure partial monosomy derived from a paternal balanced translocation is relatively rare. In this case, the submicroscopic cryptic deletion in the proband was initially elucidated by FISH, and karyotype analysis did not reveal additional chromosome abnormalities such as translocation. However, a family history of recurrent pregnancy abnormalities strongly suggested familial translocation. Sequential G-banding and FISH analysis of the father's chromosomes showed that the segment of 17p13.3-->pter was attached to the 12qter. Thus, we report a case that showed resemblance to the findings in cases of a nearly pure 17p deletion, derived from t(12;17), and delineated by whole genome array comparative genomic hybridization (CGH). If such cases are incorrectly diagnosed as Miller-Dieker syndrome caused by de novo 17p13.3 deletion, the resultant improper genetic counseling may make it difficult to exactly predict the potential risk of recurrent lissencephaly for successive pregnancies.
Abnormalities, Multiple/genetics
;
Adult
;
Brain/abnormalities
;
Chromosome Banding
;
Chromosome Segregation
;
*Chromosomes, Human, Pair 12
;
*Chromosomes, Human, Pair 17
;
Classical Lissencephalies and Subcortical Band Heterotopias/*diagnosis
;
Female
;
Gene Deletion
;
Humans
;
In Situ Hybridization, Fluorescence
;
Infant, Newborn
;
Karyotyping
;
Magnetic Resonance Imaging
;
Male
;
Phenotype
;
Risk
;
Translocation, Genetic
3.Bacteremia Caused by Corynebacterium amycolatum with a Novel Mutation in gyrA Gene that Confers High-Level Quinolone Resistance.
Seoyoung YOON ; Heejung KIM ; Yangsoon LEE ; Sinyoung KIM
The Korean Journal of Laboratory Medicine 2011;31(1):47-48
Although Corynebacterium amycolatum can cause opportunistic infections, it is commonly considered as contaminant. In this report, we present a case of bacteremia caused by C. amycolatum with a novel mutation in the gyrA gene that confers high-level quinolone resistance to the organism.
Aged, 80 and over
;
Anti-Bacterial Agents/*pharmacology
;
Bacteremia/*microbiology
;
Corynebacterium/drug effects/*genetics/isolation & purification
;
Corynebacterium Infections/*diagnosis/drug therapy
;
DNA Gyrase/*genetics
;
Drug Resistance, Bacterial/genetics
;
Fluoroquinolones/*pharmacology
;
Humans
;
Male
;
Microbial Sensitivity Tests
;
Mutation
;
Vancomycin/therapeutic use
4.Plant Root Hair in Tap Water: A Potential Cause for Diagnostic Confusion.
Sadia SHAKOOR ; Mohammad WASAY ; Afia ZAFAR ; Mohammad Asim BEG
The Korean Journal of Laboratory Medicine 2011;31(1):44-46
Plant root hairs are commonly found artifacts in parasitology specimens and may be confused with helminthes by an untrained eye. We report a case of brain tuberculoma where the tissue sample was contaminated with root hair derived from tap water; the presence of this root hair, which mimicked a larva, led to diagnostic confusion. Therefore, tap water should be considered a source of root hair and vegetable matter.
Animals
;
Brain Diseases/*diagnosis/pathology
;
*Diagnostic Errors
;
Helminthiasis/diagnosis
;
Helminths/growth & development
;
Humans
;
Larva/anatomy & histology
;
Male
;
Middle Aged
;
Plant Roots/*anatomy & histology
;
Tomography, X-Ray Computed
;
Tuberculoma/*diagnosis/pathology
;
Water
5.Application of Single-nucleotide Polymorphism and Mycobacterial Interspersed Repetitive Units-Variable Number of Tandem Repeats Analyses to Clinical Mycobacterium tuberculosis Isolates from Korea.
Go Eun CHOI ; Mi Hee JANG ; Hyun Jung CHO ; Sun Min LEE ; Jongyoun YI ; Eun Yup LEE ; Chulhun L CHANG ; Yeong Dae KIM ; Moon Bum KIM
The Korean Journal of Laboratory Medicine 2011;31(1):37-43
BACKGROUND: Single-nucleotide polymorphism (SNP) analysis is a powerful strategy for large-scale molecular population studies examining phylogenetic relationships among bacterial strains. Mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) can be easily digitized to share data among laboratories. This study applied SNP and MIRU-VNTR analyses for molecular strain typing of Mycobacterium tuberculosis isolates collected throughout Korea. METHODS: We studied 102 clinical M. tuberculosis isolates, including 6 paired strains, collected from 11 university hospitals in Korea in 2008 and 2009. SNPs were detected using hairpin primer assays, and then, MIRU-VNTR analysis was performed. RESULTS: Thirty-five SNPs contained polymorphisms that helped differentiate the 96 tested isolates. The isolates were classified into 15 clusters. The Beijing family strains were distributed within closely related clusters in the SNP dendrogram. For MIRU-VNTR analysis, the 96 isolates were divided into 12 groups. The discriminatory index in 8 of these groups (MIRU-10, -23, -26, and -31; ETR-A, -B, -C, and -F) was high (Hunter-Gaston diversity index > 0.6). Unlike the SNP method, MIRU-VNTR analysis did not identify any notable localizations of Beijing or non-Beijing family isolates in specific clusters. CONCLUSIONS: SNP and MIRU-VNTR analyses are surrogate molecular strain-typing methods for M. tuberculosis in Korea where Beijing family isolates are predominant.
Cluster Analysis
;
DNA Primers/chemistry
;
Interspersed Repetitive Sequences
;
*Minisatellite Repeats
;
Mycobacterium tuberculosis/*classification/genetics/isolation & purification
;
Phylogeny
;
*Polymorphism, Single Nucleotide
;
Republic of Korea
6.Distribution of Virulence Genes in spa Types of Methicillin-resistant Staphylococcus aureus Isolated from Patients in Intensive Care Units.
Taeksoo KIM ; Jongyoun YI ; Ki Ho HONG ; Jeong Su PARK ; Eui Chong KIM
The Korean Journal of Laboratory Medicine 2011;31(1):30-36
BACKGROUND: Various virulence factors and superantigens are encoded by mobile genetic elements. The relationship between clonal background and virulence factors differs in different geographic regions. We compared the distribution and relationship of spa types and virulence genes among methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from a tertiary hospital in 2000-01 and 2007-08. METHODS: In 2000-01 and 2007-08, 94 MRSA strains were collected from 3 intensive care units at a Korean tertiary hospital. We performed spa typing and multiplex PCR for 19 superantigen genes. RESULTS: Relatively frequent spa types were t037 (40.5%), t002, t601, and t2138 in 2000-01, and t2460 (43.9%), t002, t037, t601, t324, and t2139 in 2007-08. We identified 4 novel spa types, 2 of which were designated as t5076 and t5079. Superantigen profiles were closely linked to spa types. For example, sea, sek, and seq superantigen genes were mainly detected in t037 strains. CONCLUSIONS: Major spa types differed depending on study periods, and the distribution of superantigen genes correlated with spa type.
Bacterial Typing Techniques
;
DNA, Bacterial/chemistry
;
Genotype
;
Humans
;
Intensive Care Units/statistics & numerical data
;
Methicillin-Resistant Staphylococcus aureus/genetics/*isolation & purification/pathogenicity
;
Microbial Sensitivity Tests
;
Polymerase Chain Reaction
;
Staphylococcal Infections/microbiology
;
Superantigens/genetics
;
Virulence/genetics
;
Virulence Factors/*genetics
7.The Effects of Anti-insulin Antibodies and Cross-reactivity with Human Recombinant Insulin Analogues in the E170 Insulin Immunometric Assay.
Serim KIM ; Yeo Min YUN ; Mina HUR ; Hee Won MOON ; Jin Q KIM
The Korean Journal of Laboratory Medicine 2011;31(1):22-29
BACKGROUND: Insulin assays are affected by varying degrees of interference from anti-insulin antibodies (IAs) and by cross-reactivity with recombinant insulin analogues. We evaluated the usefulness of the E170 insulin assay by assessing IA effects and cross-reactivity with 2 analogues. METHODS: Sera were obtained from 59 type 2 diabetes patients receiving continuous subcutaneous insulin infusion and 18 healthy controls. Insulin levels were determined using an E170 analyzer. To investigate the effects of IAs, we performed IA radioimmunoassays, and analyzed the differences between directly measured insulin (direct insulin) and polyethylene glycol (PEG)-treated insulins (free, IA-unbound; total, IA-bound and unbound insulin). We performed in-vitro cross-reactivity tests with insulin aspart and insulin glulisine. RESULTS: In IA-positive patients, E170 free insulin levels measured using the E170 analyzer were significantly lower than the direct insulin levels. The mean value of the direct/free insulin ratio and IA-bound insulin, which were calculated as the difference between total and free insulin, increased significantly as endogenous IA levels increased. The E170 insulin assay showed low cross-reactivities with both analogues (< 0.7%). CONCLUSIONS: IAs interfered with E170 insulin assay, and the extent of interference correlated with the IA levels, which may be attributable to the increase in IA-bound insulin, and not to an error in the assay. The E170 insulin assay may measure only endogenous insulin since cross-reactivity is low. Our results suggest that the measurement of free insulin after PEG pre-treatment could be useful for beta cell function assessment in diabetic patients undergoing insulin therapy.
Adult
;
Aged
;
Aged, 80 and over
;
Cross Reactions
;
Diabetes Mellitus, Type 2/blood/immunology
;
Female
;
Humans
;
Infusions, Subcutaneous
;
Insulin/analogs & derivatives/*blood/chemistry/immunology
;
Insulin Antibodies/*blood
;
Male
;
Middle Aged
;
Polyethylene Glycols/chemistry
;
Radioimmunoassay/instrumentation/*methods
;
Recombinant Proteins/analysis/immunology/metabolism
8.A Case of Monoclonal Gammopathy in Extranodal Marginal Zone B-cell Lymphoma of the Small Intestine.
Do Yeun KIM ; Yong Seok KIM ; Hee Jin HUH ; Jong Sun CHOI ; Jeong Seok YEO ; Beom Seok KWAK ; Seok Lae CHAE
The Korean Journal of Laboratory Medicine 2011;31(1):18-21
Monoclonal gammopathy occurs in one-third of the patients with mucosa-associated lymphoid tissue lymphoma (MALT lymphoma). However, monoclonal gammopathy has been rarely reported in Korea. Paraprotenemia accompanying MALT lymphoma is strongly correlated with involvement of the bone marrow, and this involvement leads to the progression of the disease. Here, we present a case of a 66-yr-old man diagnosed with IgM monoclonal gammopathy and stage IV extranodal marginal zone lymphoma of the small intestine, with the involvement of the bone marrow.
Aged
;
Antineoplastic Agents/therapeutic use
;
Bone Marrow/pathology
;
Drug Therapy, Combination
;
Electrophoresis, Polyacrylamide Gel
;
Humans
;
Immunoglobulin M/analysis
;
Intestinal Neoplasms/complications/drug therapy/*pathology
;
Lymphatic Metastasis
;
Lymphoma, B-Cell, Marginal Zone/complications/drug therapy/*pathology
;
Male
;
Neoplasm Staging
;
Paraproteinemias/blood/complications/*pathology
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
9.A Case of Therapy-related Acute Lymphoblastic Leukemia with t(11;19)(q23;p13.3) and MLL/MLLT1 Gene Rearrangement.
Byong Joon YOO ; Myung Hyun NAM ; Hwa Jung SUNG ; Chae Seung LIM ; Chang Kyu LEE ; Yun Jung CHO ; Kap No LEE ; Soo Young YOON
The Korean Journal of Laboratory Medicine 2011;31(1):13-17
Therapy-related ALL (t-ALL) is a rare secondary leukemia that develops after chemotherapy and/or radiotherapy for primary malignancies. Chromosomal 11q23 abnormalities are the most common karyotypic alterations in t-ALL. The t(11;19)(q23;p13) aberration is extremely rare and has not been confirmed at the molecular genetic level. Here, we report a case of t-ALL with t(11;19)(q23;p13.3) and MLL-MLLT1 (alias ENL) gene rearrangement confirmed by cytogenetic analysis, multiplex reverse transcription-PCR (multiplex RT-PCR), and DNA sequencing in a patient who had undergone treatment for breast cancer. A 40-yr-old woman developed acute leukemia 15 months after undergoing 6 cycles of adjuvant chemotherapy (doxorubicin 60 mg/m2 and cyclophosphamide 600 mg/m2), radiation therapy (dose, 5,900 cGy), and anticancer endocrine therapy with tamoxifen. The complete blood cell counts and bone marrow examination showed increased blasts and the blasts showed B lineage immunophenotype (positive for CD19, CD34, and cytoplasmic CD79a). Cytogenetic analysis revealed the karyotype 47,XX,+X,t(11;19)(q23;p13.3)[4]/46,XX[16]. FISH analyses, multiplex RT-PCR, and DNA sequencing confirmed the MLL-MLLT1 gene rearrangement. The patient underwent induction chemotherapy with fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD) and achieved complete remission. Subsequently, she underwent consolidation chemotherapy, but died of brain ischemia in the pons and the region of the middle cerebral artery. To our knowledge, this is the first case report of t-ALL with t(11;19)(q23;p13.3) and the MLL-MLLT1 gene rearrangement.
Adult
;
Antineoplastic Agents/therapeutic use
;
Base Sequence
;
Breast Neoplasms/drug therapy/radiotherapy
;
*Chromosomes, Human, Pair 11
;
*Chromosomes, Human, Pair 19
;
Combined Modality Therapy
;
Cyclophosphamide/therapeutic use
;
Doxorubicin/therapeutic use
;
Female
;
Gene Rearrangement
;
Humans
;
Immunophenotyping
;
Karyotyping
;
Molecular Sequence Data
;
Myeloid-Lymphoid Leukemia Protein/*genetics
;
Neoplasm Proteins/*genetics
;
Nuclear Proteins/*genetics
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis/genetics
;
Sequence Analysis, DNA
;
Tamoxifen/therapeutic use
;
Transcription Factors/*genetics
;
*Translocation, Genetic
10.Acute Promyelocytic Leukemia Presenting with Central Nervous System Involvement: A Report of 2 Cases.
Misuk JI ; Hyun Sook CHI ; Seongsoo JANG ; Chan Jeoung PARK ; Jung Hee LEE ; Jong Jin SEO
The Korean Journal of Laboratory Medicine 2011;31(1):9-12
Central nervous system (CNS) involvement in acute promyelocytic leukemia (APL) is rare, and the presence of CNS symptoms at the time of diagnosis of APL is even rarer. We report 2 cases of APL presenting with CNS involvement. A 43-yr-old woman presented with easy bruising and stuporous mentality. Her complete blood count (CBC) revealed leukocytosis with increased blasts. Bone marrow (BM) analysis was carried out, and the diagnosis of APL was confirmed. This was done by cytogenetic analysis and demonstration of PML-RARalpha rearrangement by reverse transcriptase PCR in the BM cells. A lumbar puncture was performed to investigate the cause of her stuporous mentality, and her cerebrospinal fluid (CSF) analysis revealed 97% leukemic promyelocytes. Despite systemic and CNS therapy, she died due to septic shock by infection and rapid disease progression only 3 days after her admission. Another patient, a 3-yr-old girl, presented with easy bruising and epistaxis, and her CBC showed pancytopenia with increased blasts. BM studies confirmed APL. Quantitative PCR for PML-RARalpha in the BM cells revealed a PML-RARalpha/ABL ratio of 0.33 and CSF analysis revealed 9.5% leukemic promyelocytes (2 of 21 cells). She received induction chemotherapy and intrathecal therapy and achieved complete remission (CR) in the BM and CNS. She has been maintained in the CR status for the past 31 months. Thus, patients with APL must be evaluated for CNS involvement if any neurological symptoms are present at the time of diagnosis.
Adult
;
Antineoplastic Agents/therapeutic use
;
Bone Marrow Cells/metabolism/pathology
;
Central Nervous System/pathology
;
Child, Preschool
;
Contusions/etiology
;
Epistaxis/etiology
;
Female
;
Granulocyte Precursor Cells/pathology
;
Humans
;
Karyotyping
;
Leukemia, Promyelocytic, Acute/*cerebrospinal fluid/drug therapy/pathology
;
Oncogene Proteins, Fusion/analysis/genetics/metabolism
;
Reverse Transcriptase Polymerase Chain Reaction
;
Spinal Puncture
;
Tomography, X-Ray Computed
;
Tretinoin/therapeutic use